Volume 28, Number 11—November 2022
Research
Fungal Endophthalmitis Outbreak after Cataract Surgery, South Korea, 2020
Soo Jeong Yoon1, Soo Hyun Kim1, Hyun Jung Bahk, Yeong Seo Ahn, Ji Joo Lee, Hye Jin Kim, Ha Jin Lim, Min Ji Choi, Jong Hee Shin, and Yeon-Kyeng Lee
Table 1
Characteristics of patients with fungal endophthalmitis after cataract surgery, South Korea, 2020
| Characteristics | No. (%), n = 156 | Mean (+SD) |
|---|---|---|
| Sex | ||
| M | 59 (37.8) | |
| F |
97 (62.2) |
|
| Age range, y | 66.3 (10.9) | |
| <59 | 44 (28.2) | |
| 60–69 | 55 (35.2) | |
| 70–79 | 41 (26.3) | |
| >80 |
16 (10.3) |
|
| Underlying conditions* | ||
| None | 70 (44.9) | |
| >1 |
86 (55.1) |
|
| Involved eye | ||
| Left | 65 (41.7) | |
| Right |
91 (58.3) |
|
| Date of symptom onset | ||
| October 2020 | 35 (22.4) | |
| November 2020 | 92 (59.0) | |
| December 2020 | 27 (17.3) | |
| January 1–11, 2021 |
2(1.3) |
|
| Latent period, d† | 24.3 (14.8) | |
| 0–14 | 42 (26.9) | |
| 15–28 | 60 (38.5) | |
| 29–42 | 38 (24.4) | |
| 43–56 | 11 (7.1) | |
| 57–70 | 4 (2.6) | |
| 70–84 | 1 (0.6) |
*Includes hypertension, diabetes mellitus, heart disease, cerebrovascular disease, hyperlipidemia, and other conditions. †Time from surgery to clinical manifestations.
1These first authors contributed equally to this work.
Page created: October 01, 2022
Page updated: October 21, 2022
Page reviewed: October 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.